Transplantation with livers from deceased donors older than 75 years

Transplantation

Volumn 99, Issue 12, 2015, Pages 2534-2542

  Thorsen, Trygve ^a   Aandahl, Einar Martin ^a,b   Bennet, William ^c   Olausson, Michael ^c   Ericzon, Bo Göran ^d   Nowak, Greg ^d   Duraj, Frans ^e   Isoniemi, Helena ^f   Rasmussen, Allan ^g   Karlsen, Tom H ^b,h   Foss, Aksel ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BILIARY TRACT DISEASE; CONTROLLED STUDY; DECEASED DONOR; DONOR; DONOR SELECTION; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT RESPONSE; VERY ELDERLY; YOUNG ADULT; AGE; FEMALE; MALE; PATIENT SELECTION; PHYSIOLOGY; PROCEDURES; SUPPLY AND DISTRIBUTION; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; TISSUE DONORS; TRANSPLANTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84939529651     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000728     Document Type: Article

References (55)

1. Sagmeister M, Mullhaupt B, Kadry Z, et al. Cost-effectiveness of cadaveric and living-donor liver transplantation. Transplantation. 2002; 73: 616-622.
2. Longworth L, Young T, Buxton MJ, et al. Midtermcost-effectiveness of the liver transplantation program of England and Wales for three disease groups. Liver Transpl. 2003; 9: 1295-1307.
3. Aberg F, Maklin S, Rasanen P, et al. Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score. Liver Transpl. 2011; 17: 1333-1343.
4. http://ec.europa.eu/health/blood-tissues-organs/docs/ev-20121009-facts-figures.pdf. Internet, 2012.
5. Newsletter Transplant, International Figures on Donation and Transplantation 2011. 2012.
6. Eurotransplant Annual Report 2011 2012.
7. Kim WR, Stock PG, Smith JM, et al. OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplantat. 2013; 13(Suppl 1): 73-102.
8. Wertheim JA, Petrowsky H, Saab S, et al. Major challenges limiting liver transplantation in the United States. Am J Transplant. 2011; 11: 1773-1784.
9. Ghobrial RM, Freise CE, Trotter JF, et al. Donor morbidity after living donation for liver transplantation. Gastroenterology. 2008; 135: 468-476.
10. Marsh JW, Gray E, Ness R, et al. Complications of right lobe living donor liver transplantation. J Hepatol. 2009; 51: 715-724.
11. http://www.eurotransplant.org/cms/mediaobject.php?file=ar-2011.pdf. Internet, 2012.
12. Zambelli M, Andorno E, De Carlis L, et al. Full-right-full-left split liver transplantation: the retrospective analysis of an early multicenter experience including graft sharing. Am J Transplant. 2012; 12: 2198-2210.
13. Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet. 2006; 367: 225-232.
14. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006; 6: 783-790.
15. Aseni P, De Feo TM, De Carlis L, et al. A prospective policy development to increase split-liver transplantation for 2 adult recipients: results of a 12-year multicenter collaborative study. Ann Surg. 2014; 259: 157-165.
16. Ghinolfi D, Marti J, De Simone P, et al. Use of octogenarian donors for liver transplantation: a survival analysis. Am J Transplant. 2014; 14: 2062-2071.
17. Jimenez-Romero C, Clemares-Lama M, Manrique-Municio A, et al. Longterm results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years. World J Surg. 2013; 37: 2211-2221.
18. Darius T, Monbaliu D, Jochmans I, et al. Septuagenarian and octogenarian donors provide excellent liver grafts for transplantation. Transplant Proc. 2012; 44: 2861-2867.
19. Lai Q, Melandro F, Levi Sandri GB, et al. Use of elderly donors for liver transplantation: has the limit been reached? J Gastrointestin Liver Dis. 2011; 20: 383-387.
20. Álamo JM, Barrera L, Marin LM, et al. Results of liver transplantation with donors older than 70 years: a case-control study. Transplant Proc. 2011; 43: 2227-2229.
21. Faber W, Seehofer D, Puhl G, et al. Donor age does not influence 12-month outcome after orthotopic liver transplantation. Transplant Proc. 2011; 43: 3789-3795.
22. Cascales Campos PA, Romero PR, Gonzalez R, et al. Improving the waiting list by using 75-year-old donors for recipients with hepatocellular carcinoma. Transplant Proc. 2010; 42: 627-630.
23. Rauchfuss F, Voigt R, Dittmar Y, et al. Liver transplantation utilizing old donor organs: a German single-center experience. Transplant Proc. 2010; 42: 175-177.
24. Singhal A, Sezginsoy B, Ghuloom AE, et al. Orthotopic liver transplant using allografts from geriatric population in the United States: is there any age limit? Exp Clin Transplant. 2010; 8: 196-201.
25. Petridis I, Gruttadauria S, Nadalin S, et al. Liver transplantation using donors older than 80 years: a single-center experience. Transplant Proc. 2008; 40: 1976-1978.
26. Fouzas I, Sgourakis G, Nowak KM, et al. Liver transplantation with grafts from septuagenarians. Transplant Proc. 2008; 40: 3198-3200.
27. Anderson CD, Vachharajani N, Doyle M, et al. Advanced donor age alone does not affect patient or graft survival after liver transplantation. J AmColl Surg. 2008; 207: 847-852.
28. Segev DL, Maley WR, Simpkins CE, et al. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology. 2007; 46: 1907-1918.
29. Gastaca M, Valdivieso A, Pijoan J, et al. Donors older than 70 years in liver transplantation. Transplant Proc. 2005; 37: 3851-3854.
30. Borchert DH, Glanemann M, Mogl M, et al. Adult liver transplantation using liver grafts from donors over 70 years of age. Transplant Proc. 2005; 37: 1186-1187.
31. Zapletal C, Faust D, Wullstein C, et al. Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc. 2005; 37: 1182-1185.
32. Nardo B, Masetti M, Urbani L, et al. Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant. 2004; 4: 1139-1147.
33. Cescon M, Grazi GL, Ercolani G, et al. Long-term survival of recipients of liver grafts fromdonors older than 80 years: is it achievable? Liver Transpl. 2003; 9: 1174-1180.
34. Cuende N, Grande L, Sanjuan F, et al. Liver transplant with organs from elderly donors: Spanish experience with more than 300 liver donors over 70 years of age. Transplantation. 2002; 73: 1360.
35. Grazi GL, Cescon M, Ravaioli M, et al. A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant. 2001; 1: 61-68.
36. Jimenez Romero C, Moreno Gonzalez E, Colina Ruiz F, et al. Use of octogenarian livers safely expands the donor pool. Transplantation. 1999; 68: 572-575.
37. Emre S, Schwartz ME, Altaca G, et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation. 1996; 62: 62-65.
38. Greif F, Bronsther OL, Van Thiel DH, et al. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg. 1994; 219: 40-45.
39. Lerut J, Gordon RD, Iwatsuki S, et al. Biliary tract complications in human orthotopic liver transplantation. Transplantation. 1987; 43: 47-51.
40. Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg. 2011; 253: 817-825.
41. Welling TH, Heidt DG, Englesbe MJ, et al. Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl. 2008; 14: 73-80.
42. Qian YB, Liu CL, Lo CM, et al. Risk factors for biliary complications after liver transplantation . Arch Surg. 2004; 139: 1101-1105.
43. Rerknimitr R, Sherman S, Fogel EL, et al. Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc. 2002; 55: 224-231.
44. Schmucker DL. Age-related changes in liver structure and function: implications for disease ? Exp Gerontol. 2005; 40: 650-659.
45. Gordon Burroughs S, Busuttil RW. Optimal utilization of extended hepatic grafts. Surg Today. 2009; 39: 746-751.
46. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl. 2003; 9: 651-663.
47. Seehofer D, Eurich D, Veltzke-SchliekerW, et al. Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant. 2013; 13: 253-265.
48. Neumann U, Samuel D, Trunecka P, et al. A randomized multicenter study comparing a tacrolimus-based protocol with and without steroids in HCV-positive liver allograft recipients. J transplant. 2012; 2012: 894215.
49. Guo H, Chen ZH, Chen ZS, et al. Histopathological study of 268 hepatic allograft biopsies. Zhonghua Yi Xue Za Zhi. 2011; 91: 3401-3404.
50. Klintmalm GB, Davis GL, Teperman L, et al. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011; 17: 1394-1403.
51. Demetris AJ, Ruppert K, Dvorchik I, et al. Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation. 2002; 74: 1290-1296.
52. Fosby B, Karlsen TH, Melum E. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol. 2012; 18: 1-15.
53. Neil DA, Hubscher SG. Current views on rejection pathology in liver transplantation. Transpl Int. 2010; 23: 971-983.
54. Rubin A, Aguilera V, Berenguer M. Liver transplantation and hepatitis C. Clin Res Hepatol Gastroenterol. 2011; 35: 805-812.
55. http://www.who.int/gho/countries/en/.